• 1. An artificial blood vessel implanted three-dimensional microsystem for modeling transvascular migration of tumor cells?
  Xue-Ying Wang,Ying Pei,Min Xie,Zi-He Jin,Ya-Shi Xiao,Yang Wang,Li-Na Zhang,Yan Li,Wei-Hua Huang Lab Chip, 2015,15, 1178-1187
• 2. An alumina stabilized graphene oxide wrapped SnO2 hollow sphere LIB anode with improved lithium storage?
  Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789
• 3. An inter-tangled network of redox-active and conducting polymers as a cathode for ultrafast rechargeable batteries
  Jieun Kim,Han-Saem Park,Tae-Hee Kim,Sung Yeol Kim,Hyun-Kon Song Phys. Chem. Chem. Phys., 2014,16, 5295-5300
• 4. An atom-economical protocol for direct conversion of Baylis–Hillman alcohols to β-chloro aldehydes in water?
  Raktani Bikshapathi,Sai Prathima Parvathaneni,Vaidya Jayathirtha Rao Green Chem., 2017,19, 4446-4450
• 5. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli

Introduction to 2-(4-phenylpiperazin-1-yl)-1,3-thiazole-5-carbaldehyde (CAS No. 303987-39-5)

2-(4-phenylpiperazin-1-yl)-1,3-thiazole-5-carbaldehyde is a significant compound in the realm of pharmaceutical chemistry, characterized by its unique structural framework that combines a thiazole core with a phenylpiperazine moiety. This molecular architecture has garnered considerable attention due to its potential biological activities and its role as a key intermediate in the synthesis of various pharmacologically relevant molecules. The compound's Chemical Abstracts Service (CAS) number, 303987-39-5, uniquely identifies it in scientific literature and databases, facilitating precise referencing and research continuity.

The thiazole ring is a heterocyclic structure comprising sulfur and nitrogen atoms, which is well-documented for its presence in numerous bioactive natural products and synthetic drugs. Its stability and reactivity make it an attractive scaffold for medicinal chemists seeking to develop novel therapeutic agents. In contrast, the phenylpiperazine moiety is another pharmacophore frequently encountered in medicinal chemistry, particularly in the development of drugs targeting central nervous system (CNS) disorders. The combination of these two motifs in 2-(4-phenylpiperazin-1-yl)-1,3-thiazole-5-carbaldehyde suggests a compound with multifaceted biological potential.

Recent advancements in drug discovery have highlighted the importance of rational molecular design, where structural features are carefully orchestrated to optimize biological activity. The presence of both the thiazole and phenylpiperazine units in this compound suggests that it may exhibit properties relevant to multiple therapeutic areas. For instance, thiazole derivatives have been explored for their antimicrobial, anti-inflammatory, and anticancer properties, while phenylpiperazine derivatives are known for their role as serotonin receptor modulators, making them valuable in treating conditions such as depression and schizophrenia.

One of the most compelling aspects of 2-(4-phenylpiperazin-1-yl)-1,3-thiazole-5-carbaldehyde is its potential as a precursor for further chemical modifications. The aldehyde functional group at the 5-position of the thiazole ring provides a reactive site for various synthetic transformations, including condensation reactions with amines or hydrazines to form more complex heterocycles. Such modifications can be tailored to enhance specific biological activities or to improve pharmacokinetic profiles. The versatility of this compound underscores its utility in drug discovery pipelines.

In the context of current research trends, there is growing interest in developing small molecules that can modulate neurotransmitter systems without causing significant side effects. The phenylpiperazine moiety is particularly relevant here, as it has been extensively studied for its ability to interact with serotonin receptors (e.g., 5-HT1A, 5-HT2A). By integrating this moiety with the thiazole scaffold, researchers aim to create compounds that exhibit enhanced selectivity and efficacy. Preliminary studies on related derivatives have shown promise in preclinical models for treating CNS disorders.

The synthesis of 2-(4-phenylpiperazin-1-yl)-1,3-thiazole-5-carbaldehyde involves multi-step organic reactions that require careful optimization to ensure high yield and purity. Key synthetic steps typically include the formation of the thiazole ring followed by functionalization at the 5-position with an aldehyde group. Subsequent coupling with 4-(4-phenylpiperazin-1-yl)boronic acid or analogous reagents allows for the introduction of the phenylpiperazine moiety. Advances in catalytic methods, such as palladium-catalyzed cross-coupling reactions (e.g., Suzuki-Miyaura coupling), have significantly improved the efficiency of these synthetic routes.

The pharmacological evaluation of 2-(4-phenylpiperazin-1-yl)-1,3-thiazole-5-carbaldehyde has only begun to scratch the surface of its potential applications. In vitro studies have demonstrated preliminary interactions with various biological targets, suggesting possible therapeutic utility. For example, derivatives bearing similar structural motifs have been reported to exhibit antipsychotic and antidepressant activities. While more extensive research is needed to fully elucidate the pharmacological profile of this compound, these initial findings are encouraging and warrant further investigation.

The chemical properties of 2-(4-phenylpiperazin-1-yl)-1,3-thiazole-5-carbaldehyde, including its solubility profile and stability under different conditions, are also critical factors to consider in drug development. Solubility influences bioavailability and formulation design, while stability determines shelf life and storage requirements. Computational modeling techniques can be employed to predict these properties before experimental validation is undertaken. Such approaches help streamline drug discovery efforts by identifying promising candidates early in the process.

In conclusion,2-(4-phenylpiperazin-1-yi)-1,3-thiazoiee carbaaldehyde (CAS No. 303987e39-e) represents a structurally intriguing molecule with significant pharmaceutical potential. Its combination of a thiaziee core and a phenyiee piperazine moiety positions it as a valuable intermediatee iin ehe synthesis oof novel therapeutic agents targeting various diseasesee e Particularie interest has been shown iin ehese compounds' eappetential eor modulating ehentral nervous systeme neurotransmitter systems without eliciting undue side effectse Further research into ehis molecule's eharmacological profile will be essential iin determining ehether it will emerge as a lead candidate iin future drug development pipelinesee

• 92940-24-4(2-(diethylamino)-1,3-thiazole-5-carbaldehyde)
• 1263215-16-2(4-Chloro-2-(4-phenylpiperazin-1-yl)thiazole-5-carbaldehyde)
• 2877638-71-4(1-(5-methyl-1,3-thiazol-2-yl)-4-(3-methylphenyl)piperazine)
• 866756-94-7(5-THIAZOLECARBOXAMIDE, N,N-DIMETHYL-2-(PHENYLAMINO)-)
• 320423-50-5(2-(4-methylpiperazin-1-yl)-1,3-thiazole-5-carbaldehyde)
• 478079-09-3(1-Methyl-4-{5-[(4-phenylpiperazino)methyl]-1,3-thiazol-2-yl}piperazine)
• 439121-09-2(4-{5-[(4-phenylpiperazin-1-yl)methyl]-1,3-thiazol-2-yl}morpholine)
• 303987-22-6(2-(4-Benzylpiperazino)-1,3-thiazole-5-carbaldehyde)
• 439112-21-7(1-{[2-(4-Methylpiperidino)-1,3-thiazol-5-yl]methyl}-4-phenylpiperazine)
• 623588-33-0(5-THIAZOLECARBOXAMIDE, N-(2-AMINOPHENYL)-2-(1-PIPERAZINYL)-)